Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1551–1600 of 18397
On April 15, 2025, Medicine Man Technologies, Inc. (the “Company”) retained Bob Finley, a partner at FLG Partners, LLC (“FLG Partners”), a chief financial officer services and board advisory consulting firm, as the Company’s Interim Chief Financial Officer (principal financial officer and principal accounting officer).
On April 18, 2025, the Board of Directors of the Company appointed Chen Franco-Yehuda, age 41, to serve as the Company’s Chief Financial Officer, Treasurer and Secretary, effective as of May 15, 2025.
On April 18, 2025, Mr. Zvi Ben-David resigned as Chief Financial Officer, Treasurer and Secretary of DarioHealth Corp. (the “Company”), effective as of May 15, 2025.
the officers of the Company are as follows: Alan Campion, Chief Financial Officer, and Andrea Burke, Vice President.
On April 15, 2025, Mr. Vecchione notified the Company’s Board of Directors of his ability to return from his temporary leave of absence and upon such notification, the Board of Directors acted to reappoint Mr. Vecchione to the offices of President and Chief Executive Officer of the Company, effective as of April 15, 2025.
Appointment of Chief Financial Officer On April 21, 2025, Appian Corporation (the “Company”) issued a press release announcing that Srdjan “Serge” Tanjga has been appointed Chief Financial Officer of the Company, effective May 27, 2025 (the “Effective Date”).
Mr. Tanjga succeeds Mark Lynch, who has served as the Company’s Interim Chief Financial Officer since November 2024.
On April 21, 2025, MongoDB, Inc. (the “Company”) announced that Srdjan (“Serge”) Tanjga , the Company’s Interim Chief Financial Officer, and the Company’s principal financial officer under Section 16a-1(f) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), has notified the Company of his intent to resign from his position , effective May 8, 2025.
On April 15, 2025, the Company terminated Michael Jansen as the Company’s Chief Financial Officer.
On April 15, 2025, Titan Environmental Solutions Inc. (the “ Company ”) appointed Anna Skowron as the Company’s Chief Financial Officer and Secretary, effective immediately.
Peter Salzmann, M.D. retired from his roles as the Chief Executive Officer and principal executive officer of Immunovant, Inc. (the "Company" or "Immunovant"), effective April 20, 2025
Also effective April 20, 2025, Renee Barnett ceased serving as the Chief Financial Officer (including the principal financial officer and principal accounting officer) of the Company.
Jost Fisher will step down as Interim President and Chief Executive Officer but will continue to serve as chairman of the Board, a member of the audit committee and chair of the compensation committee.
On April 19, 2025, the board of directors (the “Board”) of AEON BioPharma, Inc. (the “Company”) appointed Robert Bancroft, age 60, as the Company’s Principal Executive Officer, President, Chief Executive Officer and member of the Board to serve as a Class I director, effective as of April 29, 2025.
Vice Chair and Chief Financial Officer (“CFO”) Dean Y. Shigemura, 61, will step down as CFO effective June 30, 2025.
When Mr. Shigemura exits his current role, his duties as CFO will be assumed by current Senior Executive Vice President and Deputy CFO Bradley S. Satenberg.
In connection with Mr. Ellwein's resignation, the Company's Board of Directors has appointed Brian Baker as Chief Financial Officer (principal financial officer and principal accounting officer) of the Company, effective as of May 9, 2025.
On April 15, 2025 Gabe Ellwein informed Dynatronics Corporation (the "Company") of his decision to resign as Chief Financial Officer (principal financial officer and principal accounting officer) of the Company, effective as of May 9, 2025, to pursue other professional interests.
On April 18, 2025, the Board of Directors of Two Harbors Investment Corp. (the “Company”) confirmed that William Dellal has been designated as the Company’s Vice President and Chief Financial Officer and will serve in such role until further notice.
On March 17, 2025, Avanos Medical, Inc. (the “Company”) announced the appointment of David Pacitti as the Company’s Chief Executive Officer, effective April 14, 2025.
Mr. Machan no longer serves as the Company’s Interim Chief Financial Officer effective April 14, 2025
The Company has appointed Jason M. Pickett as Interim Chief Financial Officer and Treasurer, effective April 14, 2025.
On April 18, 2025, Michael C. Greiner announced that he will leave Avanos Medical, Inc. (the “Company”) to pursue other opportunities because the Company did not offer him a position comparable to the one he held prior to his role as the Company’s Interim Chief Executive Officer.
Evan T. Scott has been appointed Chief Financial Officer to replace Mr. Malave effective April 17, 2025.
Jay Malave, its Chief Financial Officer, advised the Company of his intention to pursue other opportunities outside of the Company.
On April 17, 2025, Spirit Aviation Holdings, Inc. (“Spirit” or the “Company”) announced the appointment of David Davis as President, Chief Executive Officer of the Company and as a member of the Board of Directors of the Company (the “Board”), in each case to be effective April 21, 2025.
On April 17, 2025, CRH public limited company (‘CRH’ or the ‘Company’) announced the appointment of Nancy Buese as Chief Financial Officer, effective as of May 12, 2025.
Todd L. Capitani, the Company’s current Chief Financial Officer, who previously announced his retirement, will continue with the Company until August 15, 2025 to support this leadership transition.
On April 17, 2025 , Shore Bancshares, Inc. (the “Company”) announced that it appointed Charles S. Cullum to Executive Vice President and Chief Financial Officer effective April 21, 2025.
The disclosures set forth in Item 1.01 regarding Norman E. Snyder’s retirement and resignation from the positions of Chief Executive Officer and director and the terms of the Transition Agreement are incorporated into this section (b) by this reference.
The disclosures set forth in Item 1.01 regarding Cyril Wallace’s appointment as Chief Executive Officer and the terms of the Employment Agreement are incorporated into this section (c) by this reference.
On April 17, 2025, the Company announced the appointment of William J. Kelley Jr. to the position of Executive Vice President, Chief Financial Officer and Principal Accounting Officer, effective as of the CFO Effective Date.
On April 16, 2025, the Company and Ajay Kataria, the Company’s Executive Vice President, Chief Financial Officer and Principal Accounting Officer, mutually determined that, effective as of May 1, 2025, (the “CFO Effective Date”), Mr. Kataria would no longer serve in his roles as the Company’s Executive Vice President, Chief Financial Officer and Principal Accounting Officer
On April 16, 2025, Dave Davis, President, Chief Financial Officer and member of the board of directors (the “Board”) of Sun Country Airlines Holdings, Inc. (the “Company”), informed the Board that he would be stepping down from his position with the Company and as a member of the Board, effective immediately.
the Board has appointed Bill Trousdale as interim Chief Financial Officer and Principal Financial and Accounting Officer, effective as of April 17, 2025.
On April 17, 2025, Enovix Corporation (the “Company”) announced that Ryan Benton had been appointed as Chief Financial Officer (“CFO”) of the Company.
Upon Mr. Crehan’s departure, Michelle Chang, the Company’s Chief Financial Officer, will assume the role of the Company’s principal accounting officer.
the Board elected Don Devlin as Senior Vice President and Chief Financial Officer of Sylvamo, effective May 1, 2025
Jean-Michel Ribiéras notified the Board of Directors (“Board”) of Sylvamo Corporation (“Sylvamo”) of his decision to retire as Chief Executive Officer, effective December 31, 2025
On April 11, 2025, Dr. William McGann notified the board of directors of Quantum Computing Inc. (the “Company”) of his decision to retire and resign from his roles as Chief Executive Officer and President of the Company effective May 12, 2025
On April 11, 2025, the Board appointed Dr. Yuping Huang to serve as the Company’s Interim Chief Executive Officer and President effective upon the effectiveness of Dr. McGann’s resignation.
On April 15, 2025, Ronnie Ka Wah Hui ceased to be employed as the interim Chief Financial Officer of Currenc Group, Inc. (the “Company”).
On April 10, 2025, the Company made an offer of employment to Mr. Wan Lung Eng (“Mr. Eng”) pursuant to which Mr Eng will serve as the Company’s Chief Financial Officer (the “Employment Agreement”).
On April 15, 2025, the Company appointed Andrew Regan as Chief Executive Officer, effective immediately.
On April 10, 2025, the Board of Directors (the “Board”) of Mobix Labs, Inc. (the “Company”) appointed Philip Sansone as Interim Chief Executive Officer of the Company, effective immediately.
the Board of Directors (the “Board”) of AgEagle Aerial Systems Inc. (the “Company”) appointed Ms. Alison Burgett, age 47, to the position of Chief Financial Officer of the Company.
Ms. Anderson resigned from her position with the Company upon Ms. Burgett’s appointment to the position of Chief Financial Officer.
On April 16, 2025, the Company announced that the Board unanimously appointed Mr. Vintz and Mr. Thurmond as co-Chief Executive Officers on a permanent basis.
On April 16, 2025, the Company announced that the Board unanimously appointed Mr. Vintz and Mr. Thurmond as co-Chief Executive Officers on a permanent basis.
On July 1, 2025, Mr. Dickson will assume the duties and title of Chief Financial Officer.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.